Thursday, October 1, 2026
27.9 C
Bengaluru

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted with dismissal. They were seen as toys, not weapons—incapable of replacing the skill of a pilot, the judgment of a commander, or the discipline of a structured force. Conventional military wisdom held that war required boots on the ground, a rigid chain of command, and the controlled application of force through established hierarchies.

When drones first appeared on battlefields, military establishments reacted with dismissal. They were seen as toys, not weapons—incapable of replacing the skill of a pilot, the judgment of a commander, or the discipline of a structured force. Conventional military wisdom held that war required boots on the ground, a rigid chain of command, and the controlled application of force through established hierarchies.

Then the drones kept appearing. Not because militaries invited them, but because non-state actors, insurgents, and eventually conventional forces realized that the old system—centralized, expensive, and slow—could be bypassed. A thousand-dollar drone could do what a million-dollar jet could not: be everywhere at once, strike with asymmetric speed, and operate entirely outside the structures built to control warfare.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Topics

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...
spot_img

Related Articles

spot_imgspot_img